OXA-type carbapenemases in Acinetobacter baumannii in South America

Journal of Infection in Developing Countries

Volumn 6, Issue 4, 2012, Pages 311-316

  Opazo, Andres ^a,b   Domínguez, Mariana ^a   Bello, Helia ^a   Amyes, Sebastian G B ^b   González Rocha, Gerardo ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Chile; OXA type carbapenemases; South America

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CARBAPENEMASE OXA; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CHILE; GEOGRAPHIC DISTRIBUTION; REVIEW; SOUTH AMERICA;

EID: 84859991641     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2310     Document Type: Review

References (49)

1. Peleg A, Seifert H, Paterson D (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
2. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51: 3471-3484.
3. Livermore D and Woodford N (2006) The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 14: 413-419.
4. Nicolau D (2008) Carbapenems: a potent class of antibiotics. Expert Opin Pharmacother 9: 23-37.
5. Poirel L and Nordmann P (2006) Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12: 826-836.
6. Bonfiglio G, Russo G, Nicoletti G (2002) Recent developments in carbapenems. Expert Opin Investig Drugs 11: 529-544.
7. Queenan A and Bush K (2007) Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20: 440-458.
8. Ambler RP (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289: 321-31.
9. Bush K, Jacoby G, Medeiros A (1995) A functional classification scheme for β-lactamases and its correlation to molecular structure. Antimicrob Agents Chemother 39: 1211-1233.
10. Robledo I, Aquino E, Sante M, Santana J, Otero D, Leon C, Vazquez G (2010) Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54: 1354-1357.
11. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L (2011) Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 55: 349-354.
12. Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A (2009) Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 3: 335-341.
13. Turton J, Ward M, Woodford N, Kaufmann M, Pike R, Livermore D, Pitt T (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258: 72-77.
14. Segal H, Garny S, Elisha BG (2005) Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett 243: 425-429.
15. Vila J, Marti S. and Sanchez-Cespedes J (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59: 1210-1215.
16. Opazo A, Mella S, Dominguez M, Bello H, Gonzalez G (2009) Bombas de expulsión multidrogas en Acinetobacter baumannii y resistencia a antimicrobianos. Rev Chil Infect 26: 499-503.
17. Luo L, Jiang X, Wu Q, Wei L, Li J, Ying C (2011) Efflux pump overexpression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem. Chemotherapy 57: 77-84.
18. Poirel L, Naas T, Nordmann P (2010) Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 54: 24-38.
19. Walther-Rasmussen J and Hoiby N (2006) OXA-type carbapenemases. J Antimicrob Chemother 57: 373-383.
20. Jacoby G and Bush K (2011) http://www.lahey.org/Studies/other.asp#table1, accessed on 22 November 22 2011.
21. Paton R, Miles RS, Hood J, Amyes SGB (1993) ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2: 81-88
22. Donald HM, Scaife W, Amyes SGB, Young HK (2000) Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 44: 196-199.
23. Scaife W, Young HK, Paton RH, Amyes SGB. (1995) Transferable imipenem resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 36: 585-586.
24. Higgins P, Poirel L, Lehmann M, Nordmann P, Seiftert H (2009) OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53: 5035-5038.
25. Higgins P, Dammhayn C, Hackel M, Seifert H (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65: 233-238
26. Evans BA, Hamouda A, Towner KJ, Amyes SGB (2008) OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 14: 268-275.
27. Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J (2002) Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother 46: 2004-2006.
28. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P (2008) Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 52: 1252-1256.
29. Koh TH, Sng L, Yeng Wang G, Hsu L, Zhao Y (2007) IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 59: 627-632.
30. Poirel L, Mansour W, Bouallegue O, Nordmann (2008)a Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolysing oxacillinase OXA-97. Antimicrob Agents Chemother 52: 1613-1617.
31. Afzal-Shah M, Woodford N, Livermore D (2001) Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 45: 583-588.
32. Lu PL, Doumith M, Livermore D, Chen TP, Woodford N (2009) Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 63: 641-647.
33. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50: 1442-1448.
34. Villegas M, Kattan N, Correa A, Lolans K, Guzman A, Woodford N, Livermore D, Quinn J and the Colombian Nosocomial Bacterial Resistance Study Group (2007) Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals. Antimicrob Agents Chemother 51: 2001-2004.
35. OXA-58 in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2: 235-240.
36. OXA-23 collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 34: 25-28.
37. Schimith Bier KE, Luiz SO, Scheffer MC, Gales AC, Paganini MC, Nascimento AJ, Carignano E, Dalla Costa LM (2010) Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Am J Infect Control 38: 308-314.
38. Fernández Colón E, Bustamante García Zu, Zamora Balderrama J, Zabalaga Via S, Pinto Davalos J, Funes Espinoza F, Sevillano Peña E, Umaran Sánchez A, Gallego Andrés L (2009) Determinación de carbapenemasas y su relación con estructuras genéticas en aislamientos clínicos de Acinetobacter baumannii de hospitales de la ciudad de Cochabamba. BIOFARBO 17: 30-38.
39. Salazar E, Nieves B, Ruiz M, Ruiz J, Vila J, María A, Elsa V (2007) Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela. Med Sci Monit 13: BR89-BR94.
40. Marque S, Poirel L, Heritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann T (2005) Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 43: 4885-4888.
41. Marti S, Sanchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca Felipe, Pascual A. and Vila J (2008) Characterization of the carbapenem-hydrolyzing Oxacillinase OXA-58 in an Acinetobacter Genospecies 3 clinical isolate. Antimicrob Agents Chemother 52: 2955-2958.
42. Werneck JS, Picao RC, Carvalhaes CG, Cardoso JP, Gales AC (2010) OXA-72-producing Acinetobacter baumannii in Brazil: a case report. J Antimicrob Chemother 66: 452-454.
43. Barnaud G, Zihoune N, Richard JD, Hippeaux MC, Eveillard M, Dreyfuss D, Branger C (2010) Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect 76: 358-360.
44. Goic-Barisic I, Towner K, Kovacic A, Sisko-Kraljevic K, Tonkic M, Novak A, Punda-Polic V (2011) Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 77: 368-369.
45. Opazo-Capurro A, Bello H, Domínguez M and González-Rocha G (2010) First detection of blaOXA-24-like gene in Acinetobacter baumannii isolated from a Chilean Hospital. Abstract Book 8th International Symposium on the Biology of Acinetobacter, 1-3 September 2010; Rome, Italy pp:86
46. Brown S, Young HK, Amyes SGB (2005) Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 11: 15-23.
47. Evans BA, Hamouda A, Amyes SGB (2007) OXA-type β-lactamases in Acinetobacter baumannii: emerging from the shadow of the extended-spectrum β-lactamases. Rev Med Microbiol 18: 63-72.
48. Brown S, Bantar C, Young HK, Amyes SGB (1998) Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. The Lancet 17: 186-187.
49. Dalla Costa, L.; Coelho, J.; Souza, H.; Castro, M.; Stier, C.; Bragagnolo, K.; Rea-Neto, A.; Penteado-Filho, S.; Livermore, D.; Woodford, N. (2002). Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. 42: 119